The Harvard Drug Group LLC Gabapentin Capsules, USP, 100 mg, 100 Capsules recall: Failed Impurities/Degradation Specifications: an out of specification result
Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
The hazard: Potency, impurity or stability failure
This is a specification failure: testing showed the product does not match what the label promises.
What the notice says: Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
Why it matters: The product failed a specification test: it may contain more or less active ingredient than the label states, carry an impurity, or degrade before its expiry date. A sub-potent dose can leave a condition untreated; a super-potent one can cause an overdose.
Symptoms and when to call a doctor
The risk depends entirely on the drug. For a medicine where dose matters closely — a blood thinner, an anti-epileptic, a thyroid or heart medicine, insulin — talk to your prescriber before changing anything. Seek urgent care if you have symptoms that suggest too much drug, or if the condition the medicine controls starts breaking through.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0030-2026
- Published
- October 29, 2025
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- The Harvard Drug Group LLC
- Product type
- Prescription & OTC drugs
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot # M04950, Exp Date: 01/2026; Lot # M04989, M04990, Exp Date: 02/2026; Lot # M05056, Exp Date: 04/2026; Lot # M05150, Exp Date: 07/2026; Lot # M05290, Exp Date: 11/2026; Lot # M05312, M05342, Exp Date: 01/2027; Lot # M05369, M05386, Exp Date: 02/2027.
Products covered by this recall
Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61
Check your product
The notice names 19 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- M04950
- M04989
- M04990
- M05056
- M05150
- M05290
- M05312
- M05342
- M05369
- M05386
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 01
- 2026
- 02
- 04
- 07
- 11
- 2027
NDC number
On the carton and again on the bottle or blister label.
- 0904-6665-61
Package size
Match the net weight or the piece count on the front of the pack.
- 100 mg
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Potency
The Harvard Drug Group LLC — This is a specification failure: testing showed the product does not match what the label promises.
- Check the lot number on your pack against the codes listed above before you do anything else.
- Report any change in how the medicine is working to FDA MedWatch, which is where most of these signals originate.
- Do not stop a prescription on your own. For most conditions an uncertain dose is safer than no dose while you get advice.
- Call your prescriber or pharmacist and ask whether to swap the lot, re-test, or change nothing.
Refunds and replacements
With medicines, a replacement supply matters more than cash, and that is what pharmacies are set up to provide.
- Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
- For a mail-order or online pharmacy, use the recall line listed on this page rather than the general support queue.
- If the recall voided a fill you had already paid for, your insurer will normally authorise a replacement ahead of schedule. Quote the recall number.
- If you paid out of pocket, ask for a refund of the co-pay or purchase price and keep the receipt the pharmacy issues.
Company contact: The Harvard Drug Group LLC — 7000 Cardinal Pl, Dublin, OH, 43017-1091
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was The Harvard Drug Group LLC prescription & otc drugs recalled?
Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity . Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code M04950, M04989, M04990; best-by date 01 or 2026. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Check the lot number on your pack against the codes listed above before you do anything else.
Can I get my money back?
Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 4 months ago
The Harvard Drug Group LLC Carton Label: Major, Methylergonovine Maleate Tablets recall: Subpotent Drug
Subpotent Drug
-
Class II · 6 months ago
The Harvard Drug Group LLC Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram recall: Failed Capsule Specifications: Out of specification results obtained during
Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.
-
Class II · 6 months ago
The Harvard Drug Group LLC Memantine Hydrochloride Extended-Release, Capsules recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · 8 months ago
The Harvard Drug Group LLC Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets recall: Defective container; inadequately sealed blister packaging
Defective container; inadequately sealed blister packaging.
-
Class II · 12 months ago
The Harvard Drug Group LLC Gabapentin Capsules, USP, 100 mg, 10 Capsules recall: Failed Impurities/Degradation Specifications: an out of specification result
Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
-
Class II · 11 days ago
K.C. Pharmaceuticals, Inc. Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility